Why the study?
Does methotrexate cause ventricular arrhythmias in a patient with prior myocardial infarction?
Does methotrexate cause ventricular arrhythmias in a patient with prior myocardial infarction?
This case report highlights a potential proarrhythmic effect of methotrexate in a patient with structural heart disease, demonstrated by positive dechallenge and rechallenge.
Answers are grounded in this paper and cite their sources.
May signal methotrexate proarrhythmia risk post-MI; single case leaves open generalizability and causality.
A 36-year-old male, who 1 year previously had survived a large anterior myocardial infarction, followed by cardiac arrest, was treated a few months for psoriasis with oral methotrexate, at single weekly oral doses of up to 10 mg, when he had to be hospitalized due to anginal pain and palpitation. Repeated 24-hour electrocardiogram recordings revealed ventricular ectopy up to 580 premature beats per hour. The ventricular premature beats were almost completely abolished after a few days' discontinuation of methotrexate therapy but recurred a few hours after an attempt to restart it had been made. A coronary angiogram showed only minimal wall abnormalities. Electrophysiological testing and endomyocardial biopsy were normal.
No takes yet. Share an insight, caveat, or question.
Kettunen et al. (1995) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: